130 related articles for article (PubMed ID: 22277719)
1. Plasma glucose, insulin, free fatty acids, lactate and cortisol concentrations in dexmedetomidine-sedated dogs with or without MK-467: a peripheral α-2 adrenoceptor antagonist.
Restitutti F; Raekallio M; Vainionpää M; Kuusela E; Vainio O
Vet J; 2012 Aug; 193(2):481-5. PubMed ID: 22277719
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of dexmedetomidine, MK-467, and their combination following intravenous administration in male cats.
Pypendop BH; Honkavaara J; Ilkiw JE
J Vet Pharmacol Ther; 2016 Oct; 39(5):460-8. PubMed ID: 26896345
[TBL] [Abstract][Full Text] [Related]
3. Effects of dexmedetomidine and MK-467 on plasma glucose, insulin and glucagon in a glibenclamide-induced canine hypoglycaemia model.
Kallio-Kujala IJ; Bennett RC; Raekallio MR; Yatkin E; Meierjohann A; Savontaus E; Scheinin M; Spillmann T; Vainio OM
Vet J; 2018 Dec; 242():33-38. PubMed ID: 30503541
[TBL] [Abstract][Full Text] [Related]
4. The effects of increasing doses of MK-467, a peripheral alpha(2)-adrenergic receptor antagonist, on the cardiopulmonary effects of intravenous dexmedetomidine in conscious dogs.
Honkavaara JM; Restitutti F; Raekallio MR; Kuusela EK; Vainio OM
J Vet Pharmacol Ther; 2011 Aug; 34(4):332-7. PubMed ID: 20969603
[TBL] [Abstract][Full Text] [Related]
5. Changes in energy metabolism, and levels of stress-related hormones and electrolytes in horses after intravenous administration of romifidine and the peripheral α-2 adrenoceptor antagonist vatinoxan.
Pakkanen SAE; de Vries A; Raekallio MR; Mykkänen AK; Palviainen MJ; Sankari SM; Vainio OM
Acta Vet Scand; 2018 May; 60(1):27. PubMed ID: 29743097
[TBL] [Abstract][Full Text] [Related]
6. Effect of MK-467 on organ blood flow parameters detected by contrast-enhanced ultrasound in dogs treated with dexmedetomidine.
Restitutti F; Laitinen MR; Raekallio MR; Vainionpää M; O'Brien RT; Kuusela E; Vainio OM
Vet Anaesth Analg; 2013 Nov; 40(6):e48-56. PubMed ID: 23802592
[TBL] [Abstract][Full Text] [Related]
7. Influence of MK-467, a peripherally acting α2-adrenoceptor antagonist on the disposition of intravenous dexmedetomidine in dogs.
Honkavaara J; Restitutti F; Raekallio M; Salla K; Kuusela E; Ranta-Panula V; Rinne V; Vainio O; Scheinin M
Drug Metab Dispos; 2012 Mar; 40(3):445-9. PubMed ID: 22112381
[TBL] [Abstract][Full Text] [Related]
8. Concentrations of medetomidine enantiomers and vatinoxan, an α
Honkavaara JM; Raekallio MR; Syrja PM; Pypendop BH; Knych HK; Kallio-Kujala IJ; Vainio OM
Vet Anaesth Analg; 2020 Jan; 47(1):47-52. PubMed ID: 31761600
[TBL] [Abstract][Full Text] [Related]
9. Plasma drug concentrations and clinical effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in horses sedated with detomidine.
Vainionpää MH; Raekallio MR; Pakkanen SA; Ranta-Panula V; Rinne VM; Scheinin M; Vainio OM
Vet Anaesth Analg; 2013 May; 40(3):257-64. PubMed ID: 23368795
[TBL] [Abstract][Full Text] [Related]
10. Effects of constant rate infusions of dexmedetomidine or MK-467 on the minimum alveolar concentration of sevoflurane in dogs.
Hector RC; Rezende ML; Mama KR; Steffey EP; Knych HK; Hess AM; Honkavaara JM; Raekallio MR; Vainio OM
Vet Anaesth Analg; 2017 Jul; 44(4):755-765. PubMed ID: 28734855
[TBL] [Abstract][Full Text] [Related]
11. Haemodynamic interactions of medetomidine and the peripheral alpha-2 antagonist MK-467 during step infusions in isoflurane-anaesthetised dogs.
Kaartinen J; del Castillo JR; Salla K; Troncy E; Raekallio MR; Vainio OM
Vet J; 2014 Nov; 202(2):353-60. PubMed ID: 25201249
[TBL] [Abstract][Full Text] [Related]
12. Cardiopulmonary and sedative effects of the peripheral α2-adrenoceptor antagonist MK 0467 administered intravenously or intramuscularly concurrently with medetomidine in dogs.
Rolfe NG; Kerr CL; McDonell WN
Am J Vet Res; 2012 May; 73(5):587-94. PubMed ID: 22533388
[TBL] [Abstract][Full Text] [Related]
13. Detomidine and the combination of detomidine and MK-467, a peripheral alpha-2 adrenoceptor antagonist, as premedication in horses anaesthetized with isoflurane.
Pakkanen SA; Raekallio MR; Mykkänen AK; Salla KM; de Vries A; Vuorilehto L; Scheinin M; Vainio OM
Vet Anaesth Analg; 2015 Sep; 42(5):527-36. PubMed ID: 25529045
[TBL] [Abstract][Full Text] [Related]
14. Clinical effects and pharmacokinetic variables of romifidine and the peripheral α
de Vries A; Pakkanen SA; Raekallio MR; Ekiri A; Scheinin M; Taylor PM; Vainio OM
Vet Anaesth Analg; 2016 Nov; 43(6):599-610. PubMed ID: 26918855
[TBL] [Abstract][Full Text] [Related]
15. Dexmedetomidine Pharmacology in Neonates and Infants After Open Heart Surgery.
Su F; Gastonguay MR; Nicolson SC; DiLiberto M; Ocampo-Pelland A; Zuppa AF
Anesth Analg; 2016 May; 122(5):1556-66. PubMed ID: 26218862
[TBL] [Abstract][Full Text] [Related]
16. The cardiopulmonary effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in dogs sedated with a combination of medetomidine and butorphanol.
Salla K; Restitutti F; Vainionpää M; Junnila J; Honkavaara J; Kuusela E; Raekallio M; Vainio O
Vet Anaesth Analg; 2014 Nov; 41(6):567-74. PubMed ID: 24674053
[TBL] [Abstract][Full Text] [Related]
17. Plasma concentration and cardiovascular effects of intramuscular medetomidine combined with three doses of the peripheral alpha
Restitutti F; Kaartinen MJ; Raekallio MR; Wejberg O; Mikkola E; Del Castillo JRE; Scheinin M; Vainio OM
Vet Anaesth Analg; 2017 May; 44(3):417-426. PubMed ID: 28552594
[TBL] [Abstract][Full Text] [Related]
18. The effects of L-659,066, a peripheral α2-adrenoceptor antagonist, and verapamil on the cardiovascular influences of dexmedetomidine in conscious sheep.
Raekallio MR; Honkavaara JM; Vainio OM
J Vet Pharmacol Ther; 2010 Oct; 33(5):434-8. PubMed ID: 20840386
[TBL] [Abstract][Full Text] [Related]
19. Effects of exercise-induced stress and dexamethasone on plasma hormone and glucose concentrations and sedation in dogs treated with dexmedetomidine.
Raekallio MR; Kuusela EK; Lehtinen ME; Tykkyläinen MK; Huttunen P; Westerholm FC
Am J Vet Res; 2005 Feb; 66(2):260-5. PubMed ID: 15757125
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of dexmedetomidine, with or without MK-467, following intravenous administration in cats.
Pypendop BH; Honkavaara J; Ilkiw JE
Vet Anaesth Analg; 2017 Jan; 44(1):52-62. PubMed ID: 27377604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
